Association of circulating adipokines with metabolic dyslipidemia in obese versus non-obese individuals
- 1 January 2016
- journal article
- research article
- Published by Elsevier BV in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 10 (1), S60-S65
- https://doi.org/10.1016/j.dsx.2015.09.015
Abstract
No abstract availableKeywords
Funding Information
- Tehran University of Medical Sciences (ID: 91-02-27-18041)
This publication has 33 references indexed in Scilit:
- Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver DiseaseInternational Journal of Molecular Sciences, 2014
- Obesity EpidemiologyClinics in Colon and Rectal Surgery, 2011
- Obesity and DyslipidemiaMedical Clinics of North America, 2011
- Metabolic dyslipidemia and risk of future coronary heart disease in apparently healthy men and women: The EPIC-Norfolk prospective population studyInternational Journal of Cardiology, 2010
- Adipokines and adipocyte targets in the future management of obesity and the metabolic syndrome.Mini-Reviews in Medicinal Chemistry, 2007
- Abdominal obesity and metabolic syndromeNature, 2006
- The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivityActa Physiologica, 2005
- Adipokines: molecular links between obesity and atheroslcerosisAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Obesity: epidemiology and clinical aspectsBest Practice & Research Clinical Gastroenterology, 2004
- Adipose Tissue as an Endocrine OrganJournal of Clinical Endocrinology & Metabolism, 2004